We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle Closes Sale of Part of Performance Catalysts Unit
Read MoreHide Full Article
Albemarle Corporation (ALB - Free Report) successfully completed the earlier announced sale of its polyolefin catalysts and components business to W. R. Grace & Co. . Proceeds from the deal worth around $416 million are subject to customary post-closing adjustments.
Per the terms of the deal, the curatives and organometallics portions of the Performance Catalysts Solutions business remain with Albemarle. Grace will assume the operations and lease at the Product Development Center in Baton Rouge, LA, and operations at the Yeosu site in South Korea.
Per Albemarle, this move demonstrates its continued commitment toward portfolio management in the best interest of shareholders and employees. Grace is well placed to drive the polyolefin catalysts and components business toward success.
Shares of Albemarle have declined 14.1% in the past three months, underperforming the industry’s 6.5% gain.
Albemarle expects adjusted earnings per share for 2018 in the band of $5 to $5.40, a year-over-year increase of 9-18%. It also envisions net sales for 2018 to be between $3.2 billion and $3.4 billion. Adjusted EBITDA has been forecast in the range of $955-$1,005 million.
Albemarle, last month, received approval from Chile's Economic Development Agency for an increase in its lithium quota, enabling the company to sustainably expand its lithium production in Chile to roughly 145,000 metric tons of lithium carbonate equivalent per annum through 2043.
Per the company, this increase in quota will be enabled by deploying innovative technology for extracting more lithium without requiring additional brine pumping at the Salar de Atacama, giving it the opportunity to boost capacity in a highly sustainable and efficient manner.
LyondellBasell has an expected long-term earnings growth rate of 9%. The company’s shares have moved up 14.8% in a year.
Kronos has an expected long-term earnings growth rate of 5%. Its shares have gained 35.7% over a year.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Albemarle Closes Sale of Part of Performance Catalysts Unit
Albemarle Corporation Price and Consensus | Albemarle Corporation Quote
Zacks Rank & Stocks to Consider